MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$1,511,976
EPS
-$0.41
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Revenues
0
0
0
0
Cost of revenues
0
0
0
0
Gross profit
0
0
0
0
Research and development
459,200
541,658
465,154
501,261
Selling, general and administrative
1,080,045
888,640
776,821
731,517
Amortization of patent costs
22,918
28,855
31,059
30,742
Total expenses
1,562,163
1,459,153
1,273,034
1,263,520
Operating loss
-1,562,163
-1,459,153
-1,273,034
-1,263,520
Interest income
50,913
55,436
37,100
30,217
Total other income (expense)
50,913
55,436
37,100
30,217
Loss before provision for income taxes
-1,511,250
-1,403,717
-1,235,934
-1,233,303
Provision for income taxes
0
0
0
0
Net loss
-1,511,250
-1,403,717
-
-
Net income attributable to non-controlling interest
726
1,360
-
-
Net loss attributable to cmth
-1,511,976
-1,405,077
-1,235,934
-1,233,303
Diluted EPS
-0.41
-0.38
-0.48
-0.48
Diluted Average Shares
3,701,668
3,701,668
2,580,532
2,580,532
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to cmth
-$1,511,976
(-22.60%↓ Y/Y)
Net loss
-$1,511,250
Net income
attributable to...
$726
Interest income
$50,913
(68.49%↑ Y/Y)
Loss before
provision for income taxes
-$1,511,250
(-22.54%↓ Y/Y)
Total other income
(expense)
$50,913
(68.49%↑ Y/Y)
Operating loss
-$1,562,163
(-23.64%↓ Y/Y)
Total expenses
$1,562,163
(23.64%↑ Y/Y)
Selling, general and
administrative
$1,080,045
(47.64%↑ Y/Y)
Research and development
$459,200
(-8.39%↓ Y/Y)
Amortization of patent costs
$22,918
(-25.45%↓ Y/Y)
Buy us a coffee
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)